The Psychology of Pfizer Inc. Inc. (PFE) Price Performance: Understanding Market Sentiment

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price decrease of -42.28%. However, over the past six months, we’ve seen a stronger performance of -18.93%. The price of PFE leaped by -5.84% over the last 30 days. And in the last five days, it has fallen by -0.35%.

Currently, the stock price of Pfizer Inc. (PFE) is $29.58. In the most recent trading session, the stock underwent a significant upswing, peaking at $30.35 after opening at $29.21. The stock touched a low of $29.21 before closing at $30.19.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


In terms of market performance, Pfizer Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $54.93 on 12/14/22, while the lowest value was $28.93 on 11/13/23.

52-week price history of PFE Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Pfizer Inc.’s current trading price is -46.16% away from its 52-week high, while its distance from the 52-week low is 2.23%. The stock’s price range over this timeframe has been between $28.93 and $54.93. The shares of the Healthcare sector company recorded a trading volume of approximately 9.23 million for the day, which was comparatively lower than the average daily volume of 28.23 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Pfizer Inc. (PFE) has experienced a quarterly decline of -19.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 166.99B and boasts a workforce of 83000 employees.

Expert Opinions: Analysts’ Ratings for Pfizer Inc.

As of right now, 9 analysts are rating Pfizer Inc. as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 34.06, with a change in price of -6.77. Similarly, Pfizer Inc. recorded 26,480,773 in trading volume during the last 100 days, posting a change of -18.60%.

PFE’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PFE stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.63.

PFE Stock Stochastic Average

Pfizer Inc.’s raw stochastic average for the past 50 days is currently at 12.57%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 28.83%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 28.92% and 18.35%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts